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Collagen from bone, dentine and tendon (type I), all of which contain the pyridinoline cross-link at varying 
levels, were each digested with CNBr. The resulting peptide mixtures were resolved by gel filtration on 
Al Sm agarose and assayed for pyridinoline. The polymeric cross-linked peptide complex, polyalCB6 
[(1980) B&hem. J. 189, 1111 isolated from each of these tissues did not contain pyridinoline. Only one 
peptide fraction contained the pyridinoline cross-link; that identified as a2CB3,S. However, this peptide 
showed only a small increase in M, in its cross-linked form (approx. 2000-5000) demonstrating that pyridin- 
oline is not involved in the formation of polymeric structures like polycllCB6. These data, considered in
the light of the recent finding that pyridinoline is present in type I collagens from different sources in widely 
varying amounts, cast doubt on its role in collagen maturation. 
Collagen Cross-link Pyridinoline Pep tide Tendon Bone 
1. INTRODUCTION 
Newly formed collagen fibres are stabilised by 
divalent reducible cross-links derived from lysine 
and hydroxylysine [ 1,2]. Immature collagenous 
tissues vary in the proportion of these reducible 
keto-imine and aldimine cross-links, e.g., cartilage 
collagen contains the keto-imine, whilst dermal 
collagens possess the aldimine cross-link. During 
maturation the proportion of these keto-imine and 
aldimine cross-links falls to a low level [3] and we 
have proposed that they are intermediate cross- 
links that act as the precursors of the more com- 
plex stable cross-links of mature collagen 121. As 
all collagens are initially cross-linked by these 
reducible bonds it might be expected that a com- 
mon mechanism of age-related stabilisation exists 
resulting in the production of the ‘mature’ cross- 
links. 
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The nature of the ‘mature’ cross-links has been 
in dispute for some years. Several compounds have 
been described but no further support for them has 
been forthcoming. However, in 1977 Fujimoto and 
co-workers [4] isolated a fluorescent compound, 
named pyridinoline, from mature tendon. 
Although disputed at first [S] this compound has 
now been shown to be a cross-link of mature col- 
lagen [6-lo]. Pyridinoline is formed through the 
interaction of 3 hydroxylysine residues by a 
mechanism which may proceed either via the reac- 
tion of two keto-imine cross-links [7] or by the 
reaction of the keto-imine with a hydroxyiysine 
aldehyde [9]. 
In our approach to the identification of the 
mature cross-link we have demonstrated that the 
type I collagens in cornea, skin, tendon, bone and 
dentine are stabilised during maturation by a com- 
mon pathway involving the formation of a com- 
plex polymeric matrix which links several 
molecules in the fibre [11,12]. In all cases the in- 
teractions appeared to proceed through the alC- 
terminal peptide (cr I CB6) and the small N-terminal 
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peptides alCB5 and ~1 CB 1. Hence a common 
mechanism is apparent in type I collagen through 
the formation of the polymeric complex which we 
termed polyalCB6. We showed by several criteria 
that this polymeric complex from mature collagen 
must contain the mature cross-link [13,14]. 
Here we have investigated the location of 
pyridinoline in type I collagens from bovine bone 
and tendon and present preliminary data which in- 
dicate that only the QIZC-terminal peptide, 
cu2CB3,5, contains pyridinoline. 
2. MATERIALS AND METHODS 
Biogel Al.5 was obtained from BioRad (High 
Wycombe, Bucks); DEAE-Sepharose 6B and 
Sephadex G-10 from Pharmacia (Uppsala, 
Sweden) and [3H]lysine (399 mCi/mg) from the 
Radiochemical Centre (Amersham, Bucks). All 
chemicals and biochemicals used were analytical or 
HPLC grade and were obtained from BDH 
(Poole, Dorset) and Rathburn (Bucksburn, 
Scotland). Bovine skin, bone, dentine and achilles 
tendon were obtained fresh from mature animals 
at slaughter. 
2.1. Preparation ofpolymlCB6 and other CNBr 
pept~de fractions 
Bovine bone and dentine were splintered and 
decalcified exhaustively at 4°C in 0.25 M EDTA at 
pH 8.0. Tendons and skin were freed from 
adherent fat and were finely chopped. All tissues 
were water washed at 4°C and then suspended in 
70% (v/v) formic acid at 20-30 mg/ml (wet wt). 
PolyalCB6 was prepared after CNBr digestion on 
Al.5 m agarose in 1 M CaClt/O.OS M Tris-Cl, pH 
7.5, and DEAE-Sepharose 6B as described in 
[13,14]. 
Other CNBr peptide fractions from bovine bone 
and tendon, particularly ar2CB3,5, were prepared 
by Al.5 m agarose gel chromatography of CNBr 
peptide mixtures. In the case of bovine tendon all 
of the CNBr peptide material was pooled in several 
fractions from an Al.5 m column developed in 
1 M CaClz/0.05 M Tris-Cl, pH 7.5. Each fraction 
was dialysed at 4°C in the dark against 0.1 M 
acetic acid and the freeze-dried peptide material 
was assayed for pyridinoline after acid hydrolysis. 
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Crude (u2CB3,5 obtained from mature bovine ten- 
don by Al.5 m agarose gel filtration was further 
purified by high-performance liquid chromatog- 
raphy (HPLC) on a 25 x 0.46 cm Bakerbond C18, 
33 nm pore-size reverse-phase column as described 
[15]. Finally, 7 mg of the peptide fraction was 
chromatographed on a column (7 x 1.6 cm) of 
CM-Sepharose 6B in 0.2 M sodium citrate buffer, 
pH 3.6, essentially as in [12]. 
2.2. Acid hydroiysis and amino acid a~aiysis 
Samples of polycrlCB6 from bovine tendon, 
dentine and bone were taken up at 1 mg/ml in 6 M 
HCl and hydrolysed in sealed tubes at 110°C for 
24 h. Hydrolysates were rotary evaporated to 
dryness at 50% taken up in 0.001 M HCl and 
stored in darkness at -20°C. All samples were 
analysed as quickly as possible after production of 
peptides and always within 1 week. 
Hydrolysates were assayed for pyridinoline as 
follows. First, hydrolysates were chromatographed 
on Sephadex G-10 (95 x 1.6 cm) in 0.05 M acetic 
acid. 2-ml fractions were collected and assayed for 
fluorescence at 400 nm after excitation at 295 nm 
in a Perkin-Elmer 3000 fluorimeter. Sephadex col- 
umns were calibrated with A4, markers including 
pyridinoline (MI 450) made by the method of Fu- 
jimoto et al. 141. The fluorescent fractions with M, 
400-500 were pooled and subjected to a single col- 
umn amino acid analysis on a Jeol amino acid 
analyser in citrate buffers. Pyridinoline was iden- 
tified by its elution position and fluorescent 
characteristics [4]. 
2.3, Pyridinoline content of tu2CB3,5 peptide 
A portion of the purified cu2CB3,5 material 
from mature bovine tendon was dissolved in 0.5 M 
acetic acid and its fluorescence mission spectrum 
was obtained on excitation at 295 nm. This 
material was retained as a control whilst a second 
portion of the peptide was dissolved in 0.5 M am- 
monium bicarbonate, pH 9.5. The emission spec- 
trum of this sample was obtained with excitation at 
325 nm. Both samples were then heated at 37°C in 
the dark for 18 h. After incubation the samples 
were dialysed at 4°C in the dark against excess 
water prior to freeze drying and anaIysis by SDS- 
polyacrylamide gel electrophoresis as in [l 11. 
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3. RESULTS 
3.1. Analysis of polycvl CB6 for pyridinoline 
No trace of pyridinoline was found in 
hydrolysates of polyculCB6 from bovine skin, ten- 
don, bone or dentine by the criteria described in 
section 2. These techniques proved more than ade- 
quate to analyse and quantify pyridinoline in very 
small amounts of tissue (e.g., cartilage prepara- 
tions) or peptides containing the compound. Even 
when 20 mg polyculCB6 was analysed (in which, at 
a level of 1 mol cross-link/m01 polycvlCB6 the ex- 
pected yield would be in excess of 500 nmol) we 
could not detect pyridinoline. 
3.2. Pyridinoline in CNBr peptide fractions 
Fig.1 shows a typical elution profile for CNBr 
digested bovine tendon collagen from the Al.5 m 
agarose column. Analysis of the fractions for 
fluorescence at 400 nm showed that all peptide 
material was positive when an excitation beam at 
295 nm was used. The fractions indicated in fig. la 
were pooled and a portion of each was dried after 
dialysis and then hydrolysed in 6 M HCl. 
When these acid hydrolysates of separated 
CNBr peptides were analysed for fluorescence 
after gel filtration on Sephadex G-IO (fig.lb) only 
the fraction containing cu2CB3,5 showed a fluores- 
cent peak at A4, 450 (the reported 1!4, of 
pyridinoline, see [4]). This fraction was pooled 
(fig.lb) and shown to be pyridinoline by its posi- 
tion on the amino acid analyser and by its excita- 
tion and emission spectra at pH 3.0 and 10.0 as 
described [4]. 
3.3. Properties of purified cu2CB3,5 
cu2CB3,5 peptide was purified from the crude 
fraction 2 shown in fig.la by HPLC and ion- 
exchange chromatography (fig.2a,b). The peptide 
chromatographed as a single peak in both in- 
stances and it appeared that this peak was relative- 
ly homogeneous with respect to cu2CB3,5. The 
yield of the final product, assessed for purity by 
SDS-polyacrylamide gel electrophoresis, was ap- 
prox. 40070, most losses occurring in the ion- 
exchange step. 
Analysis of pure cu2CB3,5 for fluorescence at ex- 
citation and emission wavelengths of 295 and 
400 nm, respectively, showed very similar 
acid/alkali fluorescence spectra to those described 
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Fig. 1. (a) Separation of CNBr peptides of bovine tendon 
type I collagen by gel filtration on agarose Al.5 m. 
CNBr peptides of bovine tendon type I collagen were 
separated in 1 M CaCW0.05 M Tris-Cl, pH 7.5, on 
agarose Al.5 m was described in section 2. The effluent 
was monitored at 230 nm and for fluorescence at 
400 nm with excitation at 295 nm after acidifying each 
fraction. Fractions were pooled as shown by the bars. 
(- ) Absorbance at 230 nm, (- - -) fluorescence at 
400 nm. (b) Pyridinoline content of CNBr peptide 
fractions derived from Al.5 m gel filtration. Peptide 
fractions indicated by the bars in panel a were pooled, 
dialysed, freeze-dried and hydrolysed in 6 M HCl. The 
hydrolysates were each subjected to gel filtration on 
Sephadex G-10 in 0.05 M acetic acid and the effluents 
were monitored for fluorescence at 400 nm with 
excitation at 295 nm. HLNL, hydroxylysinonorleucine 
(ii4r 292). 
for free pyridinoline [4]. Also, when the pure 
c~2CB3,5 from mature bovine tendon was treated 
under mild alkaline conditions (which are known 
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Fig.2. Purification of cu2CB3,5 peptide from mature 
bovine tendon. (a) The crude fraction 1 from fig.1 was 
subjected to reverse-phase HPLC on a 25 x 0.46 cm 
Bakerbond 33 nm pore-size Cl8 column at 55°C and a 
flow rate of 1 ml/min. The column was equilibrated in 
a solvent containing 0.05 M ammonium bicarbonate and 
4% (v/v) trifluoroacetic acid and peptides were eluted 
with a gradient of tetrahydrofuran as described in [15]. 
The bar denotes the cr2CB3,5-rich fraction pooled. (b) 
cu2CB3,5 peptide pooled as shown in panel a was further 
purified by ion-exchange chromatography on CM- 
Sepharose 6B in 0.2 M sodium citrate buffer under 
conditions described in [12]. The pure peptide was 
pooled as indicated by the bar. 
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Fig.3. Densitometric scans of SDS-polyacrylamide gels. 
Densitometric scans of SDS-polyacrylamide gel 
electrophoretograms of ~u2CB3,5 peptide fractions from 
soluble bovine tendon collagen (i), mature bovine 
tendon collagen after treatment at pH 9.5 and 37°C for 
18 h (ii), and from mature bovine tendon but without 
any treatment prior to analysis (iii). 
to cleave pyridinoline, see [17]) the major peptide 
product migrated on SDS-polyacrylamide gels with 
a slightly greater mobility than untreated ~2CB3,5 
indicating the loss of one or more small peptides 
(fig.3). This ‘hydrolysed’ product was identical to 
cu2CB2,5 prepared from soluble type I collagen 
and contained no pyridinoline fluorescence (fig.3). 
4. DISCUSSION 
The hydroxylysine-derived collagen compound 
pyridinoline has been widely accepted as the so- 
called mature cross-link of collagen; i.e., the cross- 
linking moiety responsible for the increased stabili- 
ty of mature collagen [18]. We suggest however, 
that consideration of the available data in the 
literature and the results of the present study 
highlight certain anomalies concerning this com- 
pound which make a re-evaluation of its proposed 
role essential. 
Eyre et al. [ 181 assayed pyridinoline in various 
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tissues and reported values of l-2.6 residues/m01 
collagen in cartilage, 0.4 residue/m01 collagen in 
tendon, 0.1-0.2 residue/m01 collagen in bone and 
not detectable in skin collagen. The compound is 
known to be formed from 3 hydroxylysine residues 
so the values for bone are surprisingly low con- 
sidering the high hydroxylation of the tissue and 
suggest hat the role of pyridinoline may be dif- 
ferent in the various tissues in which it has been 
located. More recent studies have shown that type 
IV collagen, which is cross-linked only by the keto- 
imine cross-link in young tissue, does not contain 
pyridinoline [19]. On the basis of these results one 
would have to predict different mechanisms of 
stabilisation via pyridinoline for type II collagen, 
the type I collagens in skin, bone and tendon and 
for type IV collagen. Such diversity seems urpris- 
ing and leads to the speculation that other, as yet 
undiscovered, mechanisms of stabilisation may ex- 
ist which are common to all the genetic forms of 
collagen. 
Another anomaly arising from the data 
presented here is as follows. We have shown that 
type I collagens from several sources are cross- 
linked in the mature state through a polymeric net- 
work which may involve up to 10 molecules at a 
time. A complex polymeric peptide can be derived 
from this insoluble collagen by CNBr digestion 
and we have termed this material poly-c~lCB6 
[ 13,141. This material has been shown by several 
criteria to contain heat- and acid-stable cross-links 
[13] but careful analysis of the peptide complex 
from skin, tendon, bone and dentine in the present 
study showed that pyridinoline was not present. 
This is confusing as Fujimoto purified a peptide 
from a thermolysin digest of mature collagen 
which he reported to contain pyridinoline linking 
two partial alCB6 sequences and one czlCB5 se- 
quence based on amino acid analysis only [20]. 
This paradox can be resolved, however, if we con- 
sider the two peptides alCB6 and a2CB3,5, the C- 
terminal peptides of the cul and cy2 chains, respec- 
tively. Both peptides contain tyrosine and histidine 
among other residues uncharacteristic of the rest 
of the collagen molecule. Given that the major se- 
quences of the ~1 and ~2 chains are very similar 
due to the Gly-Pro-X repeat common to both, 
these similarities could explain the mis- 
interpretation of Fujimoto’s amino acid analysis 
data. In other words, Fujimoto’s thermolysin pep- 
tide [20] could have been derived from cu2CB3,5 
rather than alCB6. 
In support of this hypothesis we have now 
isolated and partially purified cu2CB3,5 peptide 
from type I collagen CNBr digests. When obtained 
from mature tissues this peptide is the only one 
derived from type I collagen which does contain 
pyridinoline. Furthermore, the peptide, in cross- 
linked form, has only a slightly elevated M, com- 
pared to the peptide prepared from soluble col- 
lagen (uncross-linked) indicating that it is cross- 
linked to very small peptides in the collagen 
molecule. 
As Sakura and Fujimoto [17] showed that 
pyridinoline is rapidly broken down by alkaline 
conditions we incubated c~2CB3,5 containing 
pyridinoline at pH 9.5 in an attempt to cleave the 
cross-link and yield uncross-linked @2CB3,5. SDS- 
polyacrylamide gel analysis of the purified peptide 
before and after alkali treatment confirmed that 
the cu2CB3,5 had been cross-linked by pyridinoline 
to other small peptides. Amino acid analysis of the 
treated peptide also confirmed that all of the 
pyridinoline had been destroyed by the mild alkali 
conditions. 
Robins and Duncan [9] have proposed a reaction 
scheme for the formation of pyridinoline in type II 
cartilage collagen which indicates that the cross- 
link only links two collagen molecules. Based on 
our evidence for the presence of pyridinoline in 
~2CB3,5 a similar mechanism of formation can be 
envisaged in type I collagen. We suggest hat since 
the C-terminal non-helical sequence of the a2 
chain lacks lysine, pyridinoline must be formed 
from condensation of the hydroxylysine aldehyde 
in the N-terminal non-helical region with the pre- 
existing keto-imine cross-link between a N- 
terminal non-helical sequence of the same 
molecule and the cu2CB3,5 helical region of an ad- 
jacent molecule. 
II = Koto - amine 
= Pyridinolino 
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Pyridinoline would therefore only cross-link two 
collagen molecules. Significantly, in this study we 
showed that pyridinoline in type I collagen was 
associated only with non-polymeric cu2CB3,5 and 
would thus be unlikely to bring about lateral cross- 
linking on the scale needed to induce the age- 
related changes in collagen seen on maturation [21] 
as would the much larger polyalCB6 complex. 
Critical review of the literature and the data in 
this report, therefore, shows that pyridinoline is 
present in highly hydroxylated collagens in 
variable amounts which may not be consistent with 
its proposed role as the stabilising cross-link of 
mature collagen. Indeed, two major tissues, skin, 
which is not highly hydroxylated, and type IV col- 
lagen, which is, both completely lack the moiety. 
Evidently, pyridinoline cannot be the only mature 
cross-link of collagen. This is corroborated by our 
study of poly-c~lCB6 which is known to account 
for the stabilisation of type I collagen on matura- 
tion yet contains no pyridinoline. Further, ex- 
amination of the location of pyridinoline both in 
type I and type II collagens ([9] and this report) has 
led to the conclusion that the cross-link may only 
link two molecules thus being an age-related in- 
tramolecular bond. In the light of these findings 
there is an evident need for further, far more 
detailed studies of the location and role of this in- 
triguing compound of collagen. 
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